Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Edward L. Giovannucci

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6123-0219; OpenAlex author ID A5038373228. Sources: OpenAlex.

Their work

Papers
51 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
90
Papers, trials and grants by year

2011: 3 papers · 2012: 3 papers · 2013: 7 papers · 2014: 3 papers · 2015: 1 paper · 2016: 4 papers · 2017: 2 papers · 2018: 5 papers · 2019: 3 papers · 2020: 4 papers · 2021: 3 papers · 2022: 2 papers · 2023: 4 papers · 2024: 1 paper · 2025: 2 papers · 2026: 4 papers

Papers 50 of 51

  1. Adherence to the Mediterranean diet and risk of pancreatic cancer: an analysis of 2.3 million participants in the Pooling Project of Prospective Studies of Die… Co-author DOI 10.1007/s10654-026-01418-x↗
  2. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  3. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  4. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  5. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  6. Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America. Co-author DOI 10.1371/journal.pmed.1004590↗
  7. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  8. Pancreatic cancer is associated with medication changes prior to clinical diagnosis. Co-author DOI 10.1038/s41467-023-38088-2↗
  9. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  10. Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. Co-author DOI 10.1158/1055-9965.epi-23-0505↗
  11. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. Co-author DOI 10.14309/ctg.0000000000000573↗
  12. The age-dependent association of risk factors with pancreatic cancer. Co-author DOI 10.1016/j.annonc.2022.03.276↗
  13. Temporal Association of Total Serum Cholesterol and Pancreatic Cancer Incidence. Last author DOI 10.3390/nu14224938↗
  14. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  15. Prediagnostic Inflammation and Pancreatic Cancer Survival. Co-author DOI 10.1093/jnci/djab040↗
  16. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  17. Diabetes, Weight Change, and Pancreatic Cancer Risk. Co-author DOI 10.1001/jamaoncol.2020.2948↗
  18. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  19. Lewis Antigen Phenotype and Survival of Patients With Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001687↗
  20. Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Co-author DOI 10.1158/1055-9965.epi-19-1389↗
  21. Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. Co-author DOI 10.1038/s41416-019-0426-5↗
  22. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  23. Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival. Co-author DOI 10.1158/1055-9965.epi-19-0577↗
  24. Statin use and pancreatic cancer risk in two prospective cohort studies. Co-author DOI 10.1007/s00535-018-1430-x↗
  25. Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence. Last author DOI 10.1007/s10552-017-0988-6↗
  26. Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. Co-author DOI 10.1016/j.cgh.2018.02.022↗
  27. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  28. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studie… Co-author DOI 10.1053/j.gastro.2017.12.001↗
  29. Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer. Co-author DOI 10.1136/gutjnl-2016-312510↗
  30. Cigarette Smoking and Pancreatic Cancer Survival. Co-author DOI 10.1200/jco.2016.71.2026↗
  31. Circulating Metabolites and Survival Among Patients With Pancreatic Cancer. Co-author DOI 10.1093/jnci/djv409↗
  32. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Co-author DOI 10.1158/0008-5472.can-16-1699↗
  33. Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival. Co-author DOI 10.1200/jco.2015.66.3005↗
  34. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  35. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus. Co-author DOI 10.1200/jco.2014.57.5688↗
  36. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  37. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Co-author DOI 10.1038/nm.3686↗
  38. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1136/gutjnl-2012-303477↗
  39. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Co-author DOI 10.1007/s10552-012-0078-8↗
  40. Nut consumption and risk of pancreatic cancer in women. Co-author DOI 10.1038/bjc.2013.665↗
  41. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. First author DOI 10.1093/jnci/djs474↗
  42. Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. Co-author DOI 10.1093/jnci/djt123↗
  43. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. First author DOI 10.1158/1055-9965.epi-12-1458↗
  44. Prediagnostic body mass index and pancreatic cancer survival. Co-author DOI 10.1200/jco.2013.51.7532↗
  45. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗
  46. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Co-author DOI 10.1093/carcin/bgs151↗
  47. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-11-0836↗
  48. Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Co-author DOI 10.1158/1055-9965.epi-11-0945-t↗
  49. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Co-author DOI 10.1002/ijc.25794↗
  50. Folate intake and risk of pancreatic cancer: pooled analysis of prospective cohort studies. Co-author DOI 10.1093/jnci/djr431↗

Closest collaborators

The 25 strongest of 90 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brian Matthew Wolpin · 27 shared papers, 2011–2023 · strength 1.69
  2. Peter Kraft · 25 shared papers, 2012–2023 · strength 1.62
  3. Chen Yuan · 20 shared papers, 2013–2023 · strength 1.49
  4. Kimmie Ng · 20 shared papers, 2012–2023 · strength 1.49
  5. Charles S. Fuchs · 27 shared papers, 2011–2023 · strength 1.46
  6. Ana Babić · 16 shared papers, 2016–2023 · strength 1.35
  7. JoAnn E. Manson · 16 shared papers, 2012–2023 · strength 0.97
  8. Qiao-Li Wang Wang · 5 shared papers, 2022–2023 · strength 0.69
  9. Jonathan Andrew Nowak · 7 shared papers, 2018–2023 · strength 0.67
  10. Vicente Morales‐Oyarvide · 10 shared papers, 2016–2021 · strength 0.65
  11. Kimberly J. Perez · 5 shared papers, 2019–2023 · strength 0.57
  12. Ying Bao · 13 shared papers, 2011–2020 · strength 0.55
  13. Natalia I. Khalaf · 7 shared papers, 2018–2021 · strength 0.55
  14. Douglas Adam Rubinson · 10 shared papers, 2013–2020 · strength 0.55
  15. Alice A. Lee · 4 shared papers, 2022–2023 · strength 0.53
  16. Zhi Rong Qian · 12 shared papers, 2013–2018 · strength 0.53
  17. Laufey Thora Amundadottir · 7 shared papers, 2013–2022 · strength 0.41
  18. Jihye Kim · 3 shared papers, 2020–2023 · strength 0.36
  19. Tsuyoshi Hamada · 5 shared papers, 2018–2019 · strength 0.35
  20. Jean Wactawski‐Wende · 4 shared papers, 2012–2023 · strength 0.33
  21. Rachael Z. Stolzenberg‐Solomon · 7 shared papers, 2011–2022 · strength 0.30
  22. NaNa Keum · 2 shared papers, 2018–2022 · strength 0.26
  23. Michael Hayden Rosenthal · 2 shared papers, 2020–2023 · strength 0.25
  24. Chris Sander · 2 shared papers, 2020–2023 · strength 0.25
  25. Fred K. Tabung · 2 shared papers, 2021–2023 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.